EXBLIFEP FDA approval date

The FDA approved EXBLIFEP on 22 Feb 2024.

FDA approval date
22 Feb 2024

Drug identity has not yet been verified against registry records

Also recorded as CEFEPIME HYDROCHLORIDE; ENMETAZOBACTAM

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2024-02-22DayEXBLIFEPFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA216165", "applicant_as_listed_by_fda": "ORCHID PHARMA", "brand_names": ["EXBLIFEP"], "active_ingredients": ["CEFEPIME HYDROCHLORIDE", "ENMETAZOBACTAM"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20240222", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026